Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer.

Saved in:
Bibliographic Details
Title: Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer.
Authors: Zanvit P; Early Oncology Research., van Dyk D; Biologics Engineering., Fazenbaker C; Early Oncology Research., McGlinchey K; Early Oncology Research., Luo W; Early Oncology Research., Pezold JM; Early Oncology Research., Meekin J; Early Oncology Research., Chang CY; Biologics Engineering., Carrasco RA; Early Oncology Research., Breen S; Early Oncology Research., Cheung CS; Biologics Engineering., Endlich-Frazier A; Biologics Engineering., Clark B; Biologics Engineering., Chu NJ; Early Oncology Research., Vantellini A; Discovery Sciences, Oncology R&D, and., Martin PL; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Hoover CE; Clinical Pathology Patient Safety, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Riley K; Clinical Pathology Patient Safety, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Sweet SM; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Chain D; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Kim YJ; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Tu E; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Harder N; Computational Pathology, AstraZeneca, Munich, Germany., Phipps S; Biologics Engineering., Damschroder M; Biologics Engineering., Gilbreth RN; Biologics Engineering., Cobbold M; Early Oncology Research., Moody G; Early Oncology Research., Bosco EE; Early Oncology Research.
Source: The Journal of clinical investigation [J Clin Invest] 2023 Nov 15; Vol. 133 (22). Date of Electronic Publication: 2023 Nov 15.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37966111
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zanvit+P%22">Zanvit P</searchLink>; Early Oncology Research.<br /><searchLink fieldCode="AU" term="%22van+Dyk+D%22">van Dyk D</searchLink>; Biologics Engineering.<br /><searchLink fieldCode="AU" term="%22Fazenbaker+C%22">Fazenbaker C</searchLink>; Early Oncology Research.<br /><searchLink fieldCode="AU" term="%22McGlinchey+K%22">McGlinchey K</searchLink>; Early Oncology Research.<br /><searchLink fieldCode="AU" term="%22Luo+W%22">Luo W</searchLink>; Early Oncology Research.<br /><searchLink fieldCode="AU" term="%22Pezold+JM%22">Pezold JM</searchLink>; Early Oncology Research.<br /><searchLink fieldCode="AU" term="%22Meekin+J%22">Meekin J</searchLink>; Early Oncology Research.<br /><searchLink fieldCode="AU" term="%22Chang+CY%22">Chang CY</searchLink>; Biologics Engineering.<br /><searchLink fieldCode="AU" term="%22Carrasco+RA%22">Carrasco RA</searchLink>; Early Oncology Research.<br /><searchLink fieldCode="AU" term="%22Breen+S%22">Breen S</searchLink>; Early Oncology Research.<br /><searchLink fieldCode="AU" term="%22Cheung+CS%22">Cheung CS</searchLink>; Biologics Engineering.<br /><searchLink fieldCode="AU" term="%22Endlich-Frazier+A%22">Endlich-Frazier A</searchLink>; Biologics Engineering.<br /><searchLink fieldCode="AU" term="%22Clark+B%22">Clark B</searchLink>; Biologics Engineering.<br /><searchLink fieldCode="AU" term="%22Chu+NJ%22">Chu NJ</searchLink>; Early Oncology Research.<br /><searchLink fieldCode="AU" term="%22Vantellini+A%22">Vantellini A</searchLink>; Discovery Sciences, Oncology R&D, and.<br /><searchLink fieldCode="AU" term="%22Martin+PL%22">Martin PL</searchLink>; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Hoover+CE%22">Hoover CE</searchLink>; Clinical Pathology Patient Safety, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Riley+K%22">Riley K</searchLink>; Clinical Pathology Patient Safety, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sweet+SM%22">Sweet SM</searchLink>; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Chain+D%22">Chain D</searchLink>; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Kim+YJ%22">Kim YJ</searchLink>; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Tu+E%22">Tu E</searchLink>; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Harder+N%22">Harder N</searchLink>; Computational Pathology, AstraZeneca, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Phipps+S%22">Phipps S</searchLink>; Biologics Engineering.<br /><searchLink fieldCode="AU" term="%22Damschroder+M%22">Damschroder M</searchLink>; Biologics Engineering.<br /><searchLink fieldCode="AU" term="%22Gilbreth+RN%22">Gilbreth RN</searchLink>; Biologics Engineering.<br /><searchLink fieldCode="AU" term="%22Cobbold+M%22">Cobbold M</searchLink>; Early Oncology Research.<br /><searchLink fieldCode="AU" term="%22Moody+G%22">Moody G</searchLink>; Early Oncology Research.<br /><searchLink fieldCode="AU" term="%22Bosco+EE%22">Bosco EE</searchLink>; Early Oncology Research.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2023 Nov 15; Vol. 133 (22). <i>Date of Electronic Publication: </i>2023 Nov 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37966111
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1172/JCI169655
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zanvit P
      – PersonEntity:
          Name:
            NameFull: van Dyk D
      – PersonEntity:
          Name:
            NameFull: Fazenbaker C
      – PersonEntity:
          Name:
            NameFull: McGlinchey K
      – PersonEntity:
          Name:
            NameFull: Luo W
      – PersonEntity:
          Name:
            NameFull: Pezold JM
      – PersonEntity:
          Name:
            NameFull: Meekin J
      – PersonEntity:
          Name:
            NameFull: Chang CY
      – PersonEntity:
          Name:
            NameFull: Carrasco RA
      – PersonEntity:
          Name:
            NameFull: Breen S
      – PersonEntity:
          Name:
            NameFull: Cheung CS
      – PersonEntity:
          Name:
            NameFull: Endlich-Frazier A
      – PersonEntity:
          Name:
            NameFull: Clark B
      – PersonEntity:
          Name:
            NameFull: Chu NJ
      – PersonEntity:
          Name:
            NameFull: Vantellini A
      – PersonEntity:
          Name:
            NameFull: Martin PL
      – PersonEntity:
          Name:
            NameFull: Hoover CE
      – PersonEntity:
          Name:
            NameFull: Riley K
      – PersonEntity:
          Name:
            NameFull: Sweet SM
      – PersonEntity:
          Name:
            NameFull: Chain D
      – PersonEntity:
          Name:
            NameFull: Kim YJ
      – PersonEntity:
          Name:
            NameFull: Tu E
      – PersonEntity:
          Name:
            NameFull: Harder N
      – PersonEntity:
          Name:
            NameFull: Phipps S
      – PersonEntity:
          Name:
            NameFull: Damschroder M
      – PersonEntity:
          Name:
            NameFull: Gilbreth RN
      – PersonEntity:
          Name:
            NameFull: Cobbold M
      – PersonEntity:
          Name:
            NameFull: Moody G
      – PersonEntity:
          Name:
            NameFull: Bosco EE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 11
              Text: 2023 Nov 15
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1558-8238
          Numbering:
            – Type: volume
              Value: 133
            – Type: issue
              Value: 22
          Titles:
            – TitleFull: The Journal of clinical investigation
              Type: main
ResultId 1